AGR2 and cancer: High AGR2 expression, as well as its secretion into body fluids, was reported in many cancer types and associated with pro‐tumorigenic phenotype and poor patient outcome (Chevet et al, 2013; Brychtova et al, 2015; Obacz et al, 2015).